Track Krishna Institute of Medical Sciences Ltd's current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: 5.53 %
Low
788.4
High
846.5
1 Month returns: 12.26 %
Low
725.4
High
846.5
1 Year returns: 24.70 %
Low
575.5
High
846.5
3 Year CAGR: 32.83 %
Low
344.0
High
846.5
5 Year CAGR: 32.48 %
Low
196.2
High
846.5
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Krishna Institute of Medical Sciences Ltd covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Krishna Institute of Medical Sciences Ltd Shareholding Pattern
Quarterly breakdown of Krishna Institute of Medical Sciences Ltd ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Krishna Institute of Medical Sciences Ltd shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Krishna Institute of Medical Sciences Ltd?
The current share price of Krishna Institute of Medical Sciences Ltd is ₹ 837.90 as of 2 Jul 2026.
What is the market capitalisation of Krishna Institute of Medical Sciences Ltd?
The market capitalisation of Krishna Institute of Medical Sciences Ltd stands at ₹ 35,192.30 Cr.
What is the PE ratio of Krishna Institute of Medical Sciences Ltd?
The Price-to-Earnings (PE) ratio of Krishna Institute of Medical Sciences Ltd is 145.78 as of the latest trailing twelve months data.
What is the ROE and ROCE of Krishna Institute of Medical Sciences Ltd?
Krishna Institute of Medical Sciences Ltd has a Return on Equity (ROE) of 10.92% and a Return on Capital Employed (ROCE) of 8.78% as per the latest financial reports.
What is the 52-week high and low of Krishna Institute of Medical Sciences Ltd?
The 52-week high of Krishna Institute of Medical Sciences Ltd is - and the 52-week low is -.
What is the dividend yield of Krishna Institute of Medical Sciences Ltd?
The dividend yield of Krishna Institute of Medical Sciences Ltd is 0.00% based on the current market price.
What is the FII and DII holding in Krishna Institute of Medical Sciences Ltd?
Foreign Institutional Investors (FII) hold 14.57%, Domestic Institutional Investors (DII) hold 32.00% and retail/public investors hold 18.71% of Krishna Institute of Medical Sciences Ltd shares.
What sector does Krishna Institute of Medical Sciences Ltd belong to?
Krishna Institute of Medical Sciences Ltd operates in the Healthcare sector. 92.31% of analysts have a Buy or Strong Buy rating on Krishna Institute of Medical Sciences Ltd with a consensus target price of ₹ 825.00, implying 1.54% downside from current levels.
What is the beta of Krishna Institute of Medical Sciences Ltd?
The beta of Krishna Institute of Medical Sciences Ltd is 0.81, indicating its price volatility relative to the broader market. Over the past 1 year, Krishna Institute of Medical Sciences Ltd has delivered an absolute return of 33.67%.
What is the RSI of Krishna Institute of Medical Sciences Ltd?
The 14-day Relative Strength Index (RSI) of Krishna Institute of Medical Sciences Ltd is 67.45, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.
Holdings and Presence
Indices and prominent investors with a stake in this stock.
Fundamental analysis overview of Krishna Institute of Medical Sciences Ltd covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Strong price momentum
Price Momentum score of 93.5 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term
What is Price Momentum score?
93.5 / 100
Strong revenue growth and above median growth of industry
The company delivered strong revenue growth of 28.65% for 12-month ended 31 Mar 2026 and the growth was 9.84 percentage points higher than median growth of industry
What is Sales growth (1Y)?
Median: 18.81
Value 28.65
-17.1910376.7
Negative
Expensive and at a premium to industry median P/E
PE TTM of 145.78 indicates that the stock is expensive on a standalone basis and is at a 195.28% premium to industry median P/E
What is P/E Ratio?
Median: 49.37
Value 145.78
-43.923248.47
Analysts have been downgrading forward EPS estimates
Analyst EPS estimate (consensus) for forward EPS has decreased by -13.72% in the last 3 months, indicating weak earnings momentum
What is Earnings upgrade (3M)?
Moderate ROE but declining trend
The company reported moderate ROE of 10.92% for 12-month ended 31 Mar 2026 but ROE declined by -847 bps from 1 year ago
What is ROE (FY)?
Moderate operating margin but declining trend
The company reported moderate operating margin of 13.29% for 12-month ended 31 Mar 2026 but operating margin declined by -667 bps from 1 year ago
What is Operating profit margin?
Low EPS growth and lower than median growth of industry
The company delivered moderate EPS growth of -37.25% for 12-month ended 31 Mar 2026 and the growth was 54.24 percentage points lower than median growth of industry
What is EPS growth (1Y)?
Reasonable Debt to Equity, but increasing
The company has reasonable Debt to Equity of 1.89 as on 31 Mar 2026 but Debt to Equity increased by 0.69 in the last 1 year
What is Debt to Equity?
Low dividend yield
The company has a low dividend yield of 0.0%
What is Dividend yield?
Neutral
Company's earnings are of moderate quality
Earnings quality score of 48.3 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
48.3 / 100
No red flags found!
No significant red flags found in the stock.
Name
Month
Transaction
Holding % pre transaction
Average price
Qty.
Transaction value
Bollineni Aishwarya
Promoter Group
December-2023
Off Market (Disposal)
30th Dec 2023
0.20 %
₹ 2,000.00
20.00 k
₹ 4.00 cr
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Company Profile
Overview of Krishna Institute of Medical Sciences Ltd covering business description, industry classification, key management, financial ratios, and listed exchange details.
Krishna Institute of Medical Sciences Ltd is an India-based company, which is primarily engaged in the business of rendering medical and healthcare services. The Companys departments include accident, Alzheimer center, andrology and Male infertility center, pediatric obesity, pediatric oncology and hematology center, pediatric orthopedics and rheumatology, pediatric renal centre, pediatric surgical centre, female urology centre, fertility centre, gastrointestinal oncology, general surgery, heart wellness center, hepatobiliary surgery center, and others. Its medical technologies include 4-Arm HD da Vinci Robotic Surgical System, O-Arm Scanner, Novalis Tx Linear Accelerator, 3 Tesla MRI, 4D Scan for pregnancy, EBUS, Spy Glass, Mako Robotic for Knee Replacement, Impella, and others. The Companys institutes include the Institute of Cardiac Sciences, Institute of Dental Science, Institute of Gastroenterology & Hepatology, Institute of Heart & Lung Transplantation, among others.
Krishna Institute of Medical Sciences Ltd is an India-based company, which is primarily engaged in the business of rendering medical and healthcare services. The Companys departments include accident, Alzheimer center, andrology and Male infertility center, pediatric obesity, pediatric oncology and ...
Key personnel
Mr. Sachin Ashok Salvi
Chief Financial Officer
Ms. Nagajayanthi J. R.
Company Secretary and Compliance Officer
Dr. Bhaskara Rao BollineniD
Executive Chairman of the Board, Managing Director